Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 126,269 | 37,689 | 22,601 | 23,260 | 35,100 |
| Cost of Goods | 742 | 589 | 1,138 | 933 | 1,052 |
| Gross Profit | 125,527 | 37,100 | 21,463 | 22,327 | 34,048 |
| Operating Expenses | 79,307 | 81,501 | 70,649 | 75,633 | 71,166 |
| Operating Income | 46,962 | -43,812 | -49,048 | -52,373 | -37,066 |
| Interest Expense | 7,940 | 8,010 | 5,001 | 5,095 | 7,072 |
| Other Income | -423 | 116 | 601 | 203 | 779 |
| Pre-tax Income | 38,599 | -51,706 | -53,448 | -57,265 | -43,359 |
| Income Tax | -121 | 106 | 134 | 149 | 62 |
| Net Income Continuous | 38,720 | -51,812 | -53,582 | -57,414 | -43,421 |
| Net Income | $38,720 | $-51,812 | $-53,582 | $-57,414 | $-43,421 |
| EPS Basic Total Ops | 7.80 | -10.34 | -10.64 | -11.54 | -8.70 |
| EPS Basic Continuous Ops | 7.80 | -10.29 | -10.68 | -11.55 | -8.69 |
| EPS Diluted Total Ops | 7.80 | -10.34 | -10.64 | -11.54 | -8.70 |
| EPS Diluted Continuous Ops | 7.80 | -10.29 | -10.68 | -11.55 | -8.69 |
| EBITDA(a) | $47,438 | $-43,157 | $-48,140 | $-51,283 | $-33,974 |